Copyright Reports & Markets. All rights reserved.

Global Terbinafine (Lamisil) Sales Market Report 2021

Request for Sample of this report
Buy now

1 Terbinafine (Lamisil) Market Overview

  • 1.1 Terbinafine (Lamisil) Product Scope
  • 1.2 Terbinafine (Lamisil) Segment by Type
    • 1.2.1 Global Terbinafine (Lamisil) Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Oral
    • 1.2.3 External Use
  • 1.3 Terbinafine (Lamisil) Segment by Application
    • 1.3.1 Global Terbinafine (Lamisil) Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Fungal Infection Of The Skin And Mucous Membrane
    • 1.3.3 Onychomycosis
    • 1.3.4 Bronchial Asthma
    • 1.3.5 Gynecological Anti-Infection Preparation
    • 1.3.6 Other
  • 1.4 Terbinafine (Lamisil) Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Terbinafine (Lamisil) Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Terbinafine (Lamisil) Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Terbinafine (Lamisil) Price Trends (2016-2027)

2 Terbinafine (Lamisil) Estimates and Forecasts by Region

  • 2.1 Global Terbinafine (Lamisil) Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Terbinafine (Lamisil) Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Terbinafine (Lamisil) Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Terbinafine (Lamisil) Revenue Market Share by Region (2016-2021)
  • 2.3 Global Terbinafine (Lamisil) Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Terbinafine (Lamisil) Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Terbinafine (Lamisil) Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Terbinafine (Lamisil) Estimates and Projections (2016-2027)
    • 2.4.2 Europe Terbinafine (Lamisil) Estimates and Projections (2016-2027)
    • 2.4.3 China Terbinafine (Lamisil) Estimates and Projections (2016-2027)
    • 2.4.4 Japan Terbinafine (Lamisil) Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Terbinafine (Lamisil) Estimates and Projections (2016-2027)
    • 2.4.6 India Terbinafine (Lamisil) Estimates and Projections (2016-2027)

3 Global Terbinafine (Lamisil) Competition Landscape by Players

  • 3.1 Global Top Terbinafine (Lamisil) Players by Sales (2016-2021)
  • 3.2 Global Top Terbinafine (Lamisil) Players by Revenue (2016-2021)
  • 3.3 Global Terbinafine (Lamisil) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Terbinafine (Lamisil) as of 2020)
  • 3.4 Global Terbinafine (Lamisil) Average Price by Company (2016-2021)
  • 3.5 Manufacturers Terbinafine (Lamisil) Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Terbinafine (Lamisil) Market Size by Type

  • 4.1 Global Terbinafine (Lamisil) Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Terbinafine (Lamisil) Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Terbinafine (Lamisil) Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Terbinafine (Lamisil) Price by Type (2016-2021)
  • 4.2 Global Terbinafine (Lamisil) Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Terbinafine (Lamisil) Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Terbinafine (Lamisil) Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Terbinafine (Lamisil) Price Forecast by Type (2022-2027)

5 Global Terbinafine (Lamisil) Market Size by Application

  • 5.1 Global Terbinafine (Lamisil) Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Terbinafine (Lamisil) Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Terbinafine (Lamisil) Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Terbinafine (Lamisil) Price by Application (2016-2021)
  • 5.2 Global Terbinafine (Lamisil) Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Terbinafine (Lamisil) Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Terbinafine (Lamisil) Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Terbinafine (Lamisil) Price Forecast by Application (2022-2027)

6 North America Terbinafine (Lamisil) Market Facts & Figures

  • 6.1 North America Terbinafine (Lamisil) Sales by Company
    • 6.1.1 North America Terbinafine (Lamisil) Sales by Company (2016-2021)
    • 6.1.2 North America Terbinafine (Lamisil) Revenue by Company (2016-2021)
  • 6.2 North America Terbinafine (Lamisil) Sales Breakdown by Type
    • 6.2.1 North America Terbinafine (Lamisil) Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Terbinafine (Lamisil) Sales Breakdown by Type (2022-2027)
  • 6.3 North America Terbinafine (Lamisil) Sales Breakdown by Application
    • 6.3.1 North America Terbinafine (Lamisil) Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Terbinafine (Lamisil) Sales Breakdown by Application (2022-2027)

7 Europe Terbinafine (Lamisil) Market Facts & Figures

  • 7.1 Europe Terbinafine (Lamisil) Sales by Company
    • 7.1.1 Europe Terbinafine (Lamisil) Sales by Company (2016-2021)
    • 7.1.2 Europe Terbinafine (Lamisil) Revenue by Company (2016-2021)
  • 7.2 Europe Terbinafine (Lamisil) Sales Breakdown by Type
    • 7.2.1 Europe Terbinafine (Lamisil) Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Terbinafine (Lamisil) Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Terbinafine (Lamisil) Sales Breakdown by Application
    • 7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)

8 China Terbinafine (Lamisil) Market Facts & Figures

  • 8.1 China Terbinafine (Lamisil) Sales by Company
    • 8.1.1 China Terbinafine (Lamisil) Sales by Company (2016-2021)
    • 8.1.2 China Terbinafine (Lamisil) Revenue by Company (2016-2021)
  • 8.2 China Terbinafine (Lamisil) Sales Breakdown by Type
    • 8.2.1 China Terbinafine (Lamisil) Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Terbinafine (Lamisil) Sales Breakdown by Type (2022-2027)
  • 8.3 China Terbinafine (Lamisil) Sales Breakdown by Application
    • 8.3.1 China 314 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 314 Sales Breakdown by Application (2022-2027)

9 Japan Terbinafine (Lamisil) Market Facts & Figures

  • 9.1 Japan Terbinafine (Lamisil) Sales by Company
    • 9.1.1 Japan Terbinafine (Lamisil) Sales by Company (2016-2021)
    • 9.1.2 Japan Terbinafine (Lamisil) Revenue by Company (2016-2021)
  • 9.2 Japan Terbinafine (Lamisil) Sales Breakdown by Type
    • 9.2.1 Japan Terbinafine (Lamisil) Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Terbinafine (Lamisil) Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Terbinafine (Lamisil) Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Terbinafine (Lamisil) Market Facts & Figures

  • 10.1 Southeast Asia Terbinafine (Lamisil) Sales by Company
    • 10.1.1 Southeast Asia Terbinafine (Lamisil) Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Terbinafine (Lamisil) Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Terbinafine (Lamisil) Sales Breakdown by Type
    • 10.2.1 Southeast Asia Terbinafine (Lamisil) Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Terbinafine (Lamisil) Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Terbinafine (Lamisil) Sales Breakdown by Application
    • 10.3.1 Southeast Asia KG Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia KG Sales Breakdown by Application (2022-2027)

11 India Terbinafine (Lamisil) Market Facts & Figures

  • 11.1 India Terbinafine (Lamisil) Sales by Company
    • 11.1.1 India Terbinafine (Lamisil) Sales by Company (2016-2021)
    • 11.1.2 India Terbinafine (Lamisil) Revenue by Company (2016-2021)
  • 11.2 India Terbinafine (Lamisil) Sales Breakdown by Type
    • 11.2.1 India Terbinafine (Lamisil) Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Terbinafine (Lamisil) Sales Breakdown by Type (2022-2027)
  • 11.3 India Terbinafine (Lamisil) Sales Breakdown by Application
    • 11.3.1 India Terbinafine (Lamisil) Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Terbinafine (Lamisil) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Terbinafine (Lamisil) Business

  • 12.1 Perrigo
    • 12.1.1 Perrigo Corporation Information
    • 12.1.2 Perrigo Business Overview
    • 12.1.3 Perrigo Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Perrigo Terbinafine (Lamisil) Products Offered
    • 12.1.5 Perrigo Recent Development
  • 12.2 Novartis Pharmaceuticals Corporation
    • 12.2.1 Novartis Pharmaceuticals Corporation Corporation Information
    • 12.2.2 Novartis Pharmaceuticals Corporation Business Overview
    • 12.2.3 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Products Offered
    • 12.2.5 Novartis Pharmaceuticals Corporation Recent Development
  • 12.3 Gokul Pharma
    • 12.3.1 Gokul Pharma Corporation Information
    • 12.3.2 Gokul Pharma Business Overview
    • 12.3.3 Gokul Pharma Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Gokul Pharma Terbinafine (Lamisil) Products Offered
    • 12.3.5 Gokul Pharma Recent Development
  • 12.4 TEVA
    • 12.4.1 TEVA Corporation Information
    • 12.4.2 TEVA Business Overview
    • 12.4.3 TEVA Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 TEVA Terbinafine (Lamisil) Products Offered
    • 12.4.5 TEVA Recent Development
  • 12.5 Mylan Pharmaceuticals
    • 12.5.1 Mylan Pharmaceuticals Corporation Information
    • 12.5.2 Mylan Pharmaceuticals Business Overview
    • 12.5.3 Mylan Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Mylan Pharmaceuticals Terbinafine (Lamisil) Products Offered
    • 12.5.5 Mylan Pharmaceuticals Recent Development
  • 12.6 Pfizer
    • 12.6.1 Pfizer Corporation Information
    • 12.6.2 Pfizer Business Overview
    • 12.6.3 Pfizer Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Pfizer Terbinafine (Lamisil) Products Offered
    • 12.6.5 Pfizer Recent Development
  • 12.7 Sivem Pharmaceuticals
    • 12.7.1 Sivem Pharmaceuticals Corporation Information
    • 12.7.2 Sivem Pharmaceuticals Business Overview
    • 12.7.3 Sivem Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Sivem Pharmaceuticals Terbinafine (Lamisil) Products Offered
    • 12.7.5 Sivem Pharmaceuticals Recent Development
  • 12.8 Apotex Corporation
    • 12.8.1 Apotex Corporation Corporation Information
    • 12.8.2 Apotex Corporation Business Overview
    • 12.8.3 Apotex Corporation Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Apotex Corporation Terbinafine (Lamisil) Products Offered
    • 12.8.5 Apotex Corporation Recent Development
  • 12.9 Auro Pharma Inc
    • 12.9.1 Auro Pharma Inc Corporation Information
    • 12.9.2 Auro Pharma Inc Business Overview
    • 12.9.3 Auro Pharma Inc Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Auro Pharma Inc Terbinafine (Lamisil) Products Offered
    • 12.9.5 Auro Pharma Inc Recent Development
  • 12.10 PLIVA
    • 12.10.1 PLIVA Corporation Information
    • 12.10.2 PLIVA Business Overview
    • 12.10.3 PLIVA Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 PLIVA Terbinafine (Lamisil) Products Offered
    • 12.10.5 PLIVA Recent Development
  • 12.11 Jamp Pharma Corporation
    • 12.11.1 Jamp Pharma Corporation Corporation Information
    • 12.11.2 Jamp Pharma Corporation Business Overview
    • 12.11.3 Jamp Pharma Corporation Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Jamp Pharma Corporation Terbinafine (Lamisil) Products Offered
    • 12.11.5 Jamp Pharma Corporation Recent Development
  • 12.12 Nu Pharm
    • 12.12.1 Nu Pharm Corporation Information
    • 12.12.2 Nu Pharm Business Overview
    • 12.12.3 Nu Pharm Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Nu Pharm Terbinafine (Lamisil) Products Offered
    • 12.12.5 Nu Pharm Recent Development
  • 12.13 Codal Synto
    • 12.13.1 Codal Synto Corporation Information
    • 12.13.2 Codal Synto Business Overview
    • 12.13.3 Codal Synto Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Codal Synto Terbinafine (Lamisil) Products Offered
    • 12.13.5 Codal Synto Recent Development
  • 12.14 Qd Pharmaceuticals
    • 12.14.1 Qd Pharmaceuticals Corporation Information
    • 12.14.2 Qd Pharmaceuticals Business Overview
    • 12.14.3 Qd Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Qd Pharmaceuticals Terbinafine (Lamisil) Products Offered
    • 12.14.5 Qd Pharmaceuticals Recent Development
  • 12.15 Pharmel Inc
    • 12.15.1 Pharmel Inc Corporation Information
    • 12.15.2 Pharmel Inc Business Overview
    • 12.15.3 Pharmel Inc Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Pharmel Inc Terbinafine (Lamisil) Products Offered
    • 12.15.5 Pharmel Inc Recent Development
  • 12.16 Smaart Pharmaceutticals
    • 12.16.1 Smaart Pharmaceutticals Corporation Information
    • 12.16.2 Smaart Pharmaceutticals Business Overview
    • 12.16.3 Smaart Pharmaceutticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.16.4 Smaart Pharmaceutticals Terbinafine (Lamisil) Products Offered
    • 12.16.5 Smaart Pharmaceutticals Recent Development
  • 12.17 Qilu Pharmaceutical
    • 12.17.1 Qilu Pharmaceutical Corporation Information
    • 12.17.2 Qilu Pharmaceutical Business Overview
    • 12.17.3 Qilu Pharmaceutical Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.17.4 Qilu Pharmaceutical Terbinafine (Lamisil) Products Offered
    • 12.17.5 Qilu Pharmaceutical Recent Development
  • 12.18 Qingdao Jinfeng Pharmaceutical
    • 12.18.1 Qingdao Jinfeng Pharmaceutical Corporation Information
    • 12.18.2 Qingdao Jinfeng Pharmaceutical Business Overview
    • 12.18.3 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.18.4 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Products Offered
    • 12.18.5 Qingdao Jinfeng Pharmaceutical Recent Development

13 Terbinafine (Lamisil) Manufacturing Cost Analysis

  • 13.1 Terbinafine (Lamisil) Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Terbinafine (Lamisil)
  • 13.4 Terbinafine (Lamisil) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Terbinafine (Lamisil) Distributors List
  • 14.3 Terbinafine (Lamisil) Customers

15 Market Dynamics

  • 15.1 Terbinafine (Lamisil) Market Trends
  • 15.2 Terbinafine (Lamisil) Drivers
  • 15.3 Terbinafine (Lamisil) Market Challenges
  • 15.4 Terbinafine (Lamisil) Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Terbinafine (Lamisil) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Terbinafine (Lamisil) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Oral
    External Use

    Segment by Application
    Fungal Infection Of The Skin And Mucous Membrane
    Onychomycosis
    Bronchial Asthma
    Gynecological Anti-Infection Preparation
    Other

    The Terbinafine (Lamisil) market is analysed and market size information is provided by regions (countries). Segment by Application, the Terbinafine (Lamisil) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Perrigo
    Novartis Pharmaceuticals Corporation
    Gokul Pharma
    TEVA
    Mylan Pharmaceuticals
    Pfizer
    Sivem Pharmaceuticals
    Apotex Corporation
    Auro Pharma Inc
    PLIVA
    Jamp Pharma Corporation
    Nu Pharm
    Codal Synto
    Qd Pharmaceuticals
    Pharmel Inc
    Smaart Pharmaceutticals
    Qilu Pharmaceutical
    Qingdao Jinfeng Pharmaceutical

    Buy now